PATENT CLAIM ANALYSIS

Application Number: 15922349
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["514", "013300"]

Abstract:
Provided herein are methods for identifying a subject with cancer for treatment with a Psap peptides. The subject is identified based on a level of CD36. Also provided herein are compositions and methods for treatment of a subject with cancer based on a level of CD36.

Claim (Index 1):
A method for evaluating a subject's responsiveness to treatment with a Psap peptide, the method comprising: determining a level of CD36 in a sample obtained from a subject having cancer, wherein an elevated level of CD36 in the sample compared to a control level indicates that the subject is responsive to or likely to be responsive to treatment with a Psap peptide.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.88462
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15684639', '15128617', '13516511', '13319476', '14131275']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7356500664856742
- 35 USC 102 Novelty (BERT): 0.5381943998010595
- Combined Prediction Score: 0.7159044998172128
- Mean Citation Score: 227.032238
- Max Citation Score: 381.15106
- Similarity Product: 259.1756581120348

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test